Cardinal Health Aktie
| 234,87USD | -0,03USD | -0,01% |
WKN: 880206 / ISIN: US14149Y1082
Personal
| 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 46 500 | 48 000 | 48 900 | 57 700 | 63 900 |
| Umsatz pro Mitarbeiter in Mio. EUR | 3,90 | 4,27 | 4,64 | 3,86 | 3,98 |
Bilanz (in Mio. USD) - Aktiva
| 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 32 935 | 33 833 | 34 884 | 36 373 | 38 753 |
| Summe Anlagevermögen | 10 943 | 9 584 | 10 237 | 16 749 | 18 546 |
| Summe Aktiva | 43 878 | 43 417 | 45 121 | 53 122 | 57 299 |
Bilanz (in Mio. USD) - Passiva
| 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 44 584 | 46 268 | 48 333 | 55 756 | 60 023 |
| Summe Eigenkapital | -706 | -2 851 | -3 212 | -2 634 | -2 724 |
| Summe Passiva | 43 878 | 43 417 | 45 121 | 53 122 | 57 299 |
Adresse
| 7000 Cardinal Place, 43017 Dublin | |
| Telefon | +1 (614) 757-5000 |
| Internet | http://www.cardinalhealth.com |
Management
|
Aaron E. Alt
Chief Financial Officer |
|
Akhil Johri
Independent Director |
|
Ben Brinker
President-Global Operations & Supply Chain |
|
Christine Ann Mundkur
Independent Director |
|
Craig Cowman
President-Biopharma Solutions & Strategic Sourcing |
|
David C. Evans
Independent Director |
|
Debbie Weitzman
Chief Executive Officer-Pharmaceutical Segment |
|
Dennis David
Vice President-Strategy & Business Development |
|
Jason M. Hollar
Chief Executive Officer & Director |
|
Jessica L. Mayer
Chief Compliance & Legal Officer |
|
Lisa Capodici
Vice President-Investor Relations |
|
Mary C. Scherer
Chief Accounting Officer & Senior Vice President |
|
Matt Sims
Vice President-Investor Relations |
|
Michelle D. Greene
Chief Information Officer & Executive VP |
|
Michelle M. Brennan
Independent Director |
|
Nancy Killefer
Independent Director |
|
Patricia A. Hemingway Hall
Chairman |
|
Patrick Pope
Secretary, Executive VP & General Counsel |
|
Robert Musslewhite
Independent Director |
|
Robert W. Azelby
Independent Director |
|
Sheri H. Edison
Independent Director |
|
Stephen M. Mason
CEO-Global Medical Products & Distribution segment |
|
Sudhakar Ramakrishna
Independent Director |
|
Valerie Pitteroff
Chief Human Resources Officer |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.